Status:
COMPLETED
Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting
Lead Sponsor:
Seoul National University Hospital
Conditions:
Radiotherapy Induced Nausea and Vomiting
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is: 1. To compare prophylactic effect of ondansetron versus ramosetron on radiotherapy induced nausea and vomiting in the treatment of gastrointestinal cancer. 2. To verify ...
Eligibility Criteria
Inclusion
- AJCC 1-3 staged gastrointestinal cancer patient
- patient undergoing radiotherapy as treatment
- age 20 yr and higher
- ECOG 0-2
Exclusion
- age \< 20
- ECOG 3-4
- patient experiencing nausea or vomiting prior to accrual
- patient under antiemetic medication
- patient under steroid medication (topical or inhalant steroid application are exceptional)
- patient under opioid medication
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT00971399
Start Date
September 1 2009
Last Update
February 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744